Under-utilization of capillary glucose monitoring by type 2 diabetic patients

Diabetes Research and Clinical Practice

Volumn 75, Issue 1, 2007, Pages 123-125

  Brindisi, Marie Claude ^a   Hahn, Jina ^b   Chiasson, Jean Louis ^a   Rabasa Lhoret, Rémi ^a,c  

^a Centre Hospitalier   (Canada)

^b NOVO NORDISK A S   (Denmark)

^c UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Glycemic control; Postprandial hyperglycemia

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

ARTICLE; CANADA; CONTROLLED STUDY; DIET; EVALUATION; EXERCISE; GENERAL PRACTITIONER; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT MONITORING; PHYSICIAN; QUESTIONNAIRE;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; HUMANS; MONITORING, PHYSIOLOGIC; POSTPRANDIAL PERIOD;

EID: 33845212402     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.05.005     Document Type: Article

References (13)

1. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329 (1993) 977-986
2. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
3. Nathan D.M., et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N. Engl. J. Med. 353 (2005) 2643-2653
4. Ceriello A. The possible role of postprandial hyperglycaemia in the pathogenesis of diabetic complications. Diabetologia 46 Suppl. 1 (2003) M9-M16
5. Bonora E., and Muggeo M. Postprandial blood glucose as a risk factor for cardiovascular disease in type II diabetes: the epidemiological evidence. Diabetologia 44 (2001) 2107-2114
6. The DECODE Study Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-h diagnostic criteria. Arch. Intern. Med. 161 (2001) 397-405
7. Monnier L., Lapinski H., and Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA (1c). Diabetes Care 26 (2003) 881-885
8. Bonora E., Calcaterra F., Lombardi S., Bonfante N., Formentini G., Bonadonna R.C., et al. Plasma glucose levels throughout the day and HbA (1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control. Diabetes Care 24 (2001) 2023-2029
9. Monnier L., Colette C., Rabasa-Lhoret R., Lapinski H., Caubel C., Avignon A., et al. Morning hyperglycemic excursions: a constant failure in the metabolic control of non-insulin-using patients with type 2 diabetes. Diabetes Care 25 (2002) 737-741
10. Bonora E., Corrao G., Bagnardi V., Ceriello A., Comaschi M., Montanari P., et al. Prevalence and correlates of post-prandial hyperglycaemia in a large sample of patients with type 2 diabetes mellitus. Diabetologia 49 (2006) 846-854
11. Bergenstal R.M., Gavin J.R., and Global Consensus Conference on Glucose Monitoring Panel. The role of self-monitoring of blood glucose in the care of people with diabetes: report of a global consensus conference. Am. J. Med. 118 Suppl. 9A (2005) 1S-6S
12. Canadian Diabetes Association. Clinical practice guidelines for the prevention and management of diabetes in Canada. Can. J. Diabetes 27 Suppl. 2 (2003) S18-S20
13. Harris S.B., Ekoe J.M., Zdanowicz Y., and Webster-Bogaert S. Glycemic control and morbidity in the Canadian primary care setting (results of the diabetes in Canada evaluation study). Diabetes Res. Clin. Practice 70 (2005) 90-97